A detailed history of Aqr Capital Management LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 34,265 shares of BMEA stock, worth $122,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,265
Holding current value
$122,326
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$3.88 - $12.41 $132,948 - $425,228
34,265 New
34,265 $132,000
Q3 2023

Nov 14, 2023

SELL
$13.44 - $23.02 $25,226 - $43,208
-1,877 Reduced 15.02%
10,622 $146,000
Q2 2023

Aug 14, 2023

BUY
$21.66 - $41.8 $270,728 - $522,458
12,499 New
12,499 $274,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $105M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.